BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other diseases.
- Sector: Healthcare
- Industry: Biotechnology
- Full Time Employees: 1,179
- Founded in 2008
- HQ in Mainz, Germany
- http://www.biontech.de
BioNTech priced 10 mln share IPO at $15.00, the low-end of the reduced $15.00-$16.00 range
No comments:
Post a Comment